Evaluation of Dependence and Nicotine Replacement Therapy-Supported Cessation Efforts Among Regular Electronic Cigarette Use

Conditions

• Cessation, Nicotine
• Cessation, Tobacco
• E Cigarette Use

Eligibility Criteria

Sex

ALL

Age

21 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Nicotine Replacement Therapies — DRUG
  Combination NRT (long-acting patch + fast-acting lozenge or gum) was observed to be safe and potentially effective for promoting ECIG cessation. Consequently, participants assigned to the NRT condition will be given patches+lozenges in their choice of flavor. The doses administered will be based on how soon after awakening that they report vaping: \<30 min (21 mg patch; 4 mg lozenge) or \>30 min (21 mg patch; 2 mg lozenge).
• Brief Behavioral Counseling — BEHAVIORAL
  Participants in both conditions will experience a brief behavioral support intervention based on the Gold Standard Program for Tobacco Cessation. The components of this program include motivational conversation, education on the risks of vaping, participants' thoughts about quitting vaping, challenges that may occur when attempting to quit vaping, and strategies to prevent relapse.

Study Details

This study aims to improve understanding of how people who use electronic cigarettes (ECIGs or e-cigarettes) respond when they try to stop using them and whether nicotine replacement therapy (NRT) can make that process easier. NRT products, such as nicotine patches and lozenges, are approved medications that help reduce nicotine withdrawal symptoms by providing nicotine without the harmful chemicals found in tobacco smoke or e-cigarette aerosol. The study has two parts. During the first part, all participants will continue using their own e-cigarettes as they normally would for three days. This allows researchers to understand each participant's typical e-cigarette use before any changes are made. In the second part, participants will be randomly assigned to one of two groups. One group will receive nicotine replacement therapy, including nicotine patches and nicotine lozenges, to use for up to seven days. The first two days are intended to help participants adjust to the medications while they continue using their e-cigarettes. During the following five days, participants will be encouraged to stop using their e-cigarettes while continuing to use the nicotine replacement products. The other group will be asked to stop using all nicotine and tobacco products for five days without receiving nicotine replacement therapy. Throughout the study, researchers will regularly ask participants about their cravings, withdrawal symptoms, motivation to quit, and experiences using or not using e-cigarettes. Researchers will also measure how much participants use their e-cigarettes and assess exposure to nicotine and other chemicals. The information collected will help researchers better understand whether nicotine replacement therapy can support people who are trying to stop using e-cigarettes. It will also help identify the most accurate ways to measure e-cigarette use and abstinence in future research, which may improve the development and evaluation of treatments for e-cigarette dependence.

Key Dates

First listed

Aug 26, 2026

Start date

Sep 1, 2026

Status verified

Aug 2026

Primary completion

Jun 30, 2028

Completion

Jun 30, 2028

Study Design

Enrollment

100 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Active Comparator: Brief Behavioral Counseling
  Participants will receive brief behavioral counseling on quitting e-cigarettes, including information about the risks of vaping, strategies for quitting, and ways to prevent relapse.
• Experimental: Brief Behavioral Counseling + NRT
  Participants will receive brief behavioral counseling on quitting e-cigarettes, including information about the risks of vaping, strategies for quitting, and ways to prevent relapse. Participants will use nicotine patches (21 mg patch) and lozenges (2 and 4 mg).

Primary Outcome Measure

Subjective Measures. [ Time Frame: From baseline (i.e., Day 1) through study completion, an average of 10 days. ]

Central Contacts

• Melissa D Blank, Ph.D
  304-293-0551
  [email protected]

Locations (2)

Find similar trials in Greenville, NC

Related Studies

• Adapting an Intervention for Vaping in Young Veterans
  Recruiting · Veterans Medical Research Foundation · San Diego, California
• Parents Helping Parents for Youth Vaping Cessation
  Recruiting · University of Nebraska · Omaha, Nebraska